Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2008 Feb;118(2):474-8. doi: 10.1172/JCI34613.

Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1.

Author information

  • 1Ludwig Institute for Cancer Research, Department of Medicine, and Department of Neuroscience, UCSD, La Jolla, California 92030, USA.

Abstract

Mutation in superoxide dismutase-1 (SOD1) causes the inherited degenerative neurological disease familial amyotrophic lateral sclerosis (ALS), a non-cell-autonomous disease: mutant SOD1 synthesis in motor neurons and microglia drives disease onset and progression, respectively. In this issue of the JCI, Harraz and colleagues demonstrate that SOD1 mutants expressed in human cell lines directly stimulate NADPH oxidase (Nox) by binding to Rac1, resulting in overproduction of damaging ROS (see the related article beginning on page 659). Diminishing ROS by treatment with the microglial Nox inhibitor apocynin or by elimination of Nox extends survival in ALS mice, reviving the proposal that ROS mediate ALS pathogenesis, but with a new twist: it's ROS produced by microglia.

PMID:
18219386
PMCID:
PMC2213376
DOI:
10.1172/JCI34613
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Journal of Clinical Investigation Icon for PubMed Central
    Loading ...
    Support Center